Zobrazeno 1 - 10
of 154
pro vyhledávání: '"Hisashi GONDO"'
Autor:
Koji Kato, Yuju Ohno, Shoshu Mitsuyama, Satoshi Toyoshima, Junichi Ito, Hisashi Gondo, Mine Harada
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 1 (2007)
Anaplastic thyroid carcinoma (ATC) is a tumor with bad prognosis and long-term survival is very low. However, appropriate combinations of chemotherapy, surgery, and radition have been reported to potentially improve the treatment results for ATC. We
Externí odkaz:
https://doaj.org/article/38aaaded45874bef8ea3bee3b0568140
Autor:
Shinichiro Okamoto, Takehiko Mori, Junya Kanda, Yoshinobu Kanda, Hisashi Gondo, Jun Kato, Masaki Inaba, Goichi Yoshimoto, Yoshihisa Kodera, Sayaka Doi, Katsuto Takenaka
Publikováno v:
International journal of hematology. 105(2)
Cytomegalovirus (CMV) infection/reactivation is a serious complication after hematopoietic cell transplantation (HCT). The DNA vaccine ASP0113 contains two plasmids encoding CMV antigens (glycoprotein B and tegument phosphoprotein 65) that stimulate
Autor:
Yukiyoshi Moriuchi, Naokuni Uike, Koichi Ohshima, Hiroyuki Tsuda, Tomohiko Kamimura, Ritsuko Seki, Tetsuya Eto, Fumio Kawano, Shigeyoshi Makino, Tomoaki Fujisaki, Hisashi Gondo, Kazuya Shimoda, Fumihiro Taguchi, Takashi Okamura
Publikováno v:
Annals of Oncology. 21:833-841
Background: The F-box protein S-phase kinase-associated protein 2 (Skp2) positively regulates the G1-S transition by promoting degradation of the cyclin-dependent kinase inhibitor p27 kip1 (p27). Recent evidence has indicated an oncogenic role of Skp
Autor:
Masakazu Higuchi, Minoru Yoshida, Koichi Ohshima, Kazuo Tamura, Kiyoshi Yamashita, Tetsuya Eto, Masahiro Iwahashi, Kazuya Shimoda, Fumihiro Taguchi, Ryosuke Ogawa, Yasunobu Abe, Kunihiro Tsukazaki, Fumio Kawano, Tomoaki Fujisaki, Hisashi Gondo, Keiko Suzuki, Naokuni Uike, Ritsuko Seki, Hitoshi Suzushima, Tadashi Matsumoto, Tomohiko Kamimura, Shigeyoshi Makino, Takashi Okamura, Atae Utsunomiya, Junji Suzumiya, Yukiyoshi Moriuchi, Yutaka Imamura, Hiroyuki Tsuda, Koji Nagafuji
Publikováno v:
International Journal of Hematology. 91:258-266
We performed a retrospective analysis of patients with diffuse large B cell lymphoma treated with rituximab plus CHOP (cyclophosphamide, adriamycin, vincristine and prednisone) as a first-line therapy at 22 hospitals of the Kyushu Lymphoma Study Grou
Autor:
Morio Sawamura, Kazutaka Sunami, Norihiko Hino, Yoshinobu Takemoto, Takaaki Chou, Ishikazu Mizuno, Hiroyuki Tsuda, Akira Miyata, Shigehisa Tamaki, Akiyoshi Miwa, Katsuji Shinagawa, Chihiro Shimazaki, Yoshio Saburi, Akira Sakai, Yutaka Imamura, Fumihito Tajima, Hisashi Gondo, Tomohiko Kamimura, Mine Harada
Publikováno v:
International Journal of Hematology. 90:635-642
The efficacy and safety of high-dose chemotherapy with tandem autologous peripheral blood stem cell transplantation (auto-PBSCT) were evaluated in a multicenter clinical study of patients with advanced multiple myeloma. Eligible patients (n = 40) wer
Autor:
Tadashi Matsumoto, Minoru Yoshida, Yutaka Imamura, Naokuni Uike, Hitoshi Suzushima, Junji Suzumiya, Keiko Suzuki, Ritsuko Seki, Yukiyoshi Moriuchi, Tetsuya Eto, Kazuya Shimoda, Takashi Okamura, Atae Utsunomiya, Fumio Kawano, Tomoaki Fujisaki, Fumihiro Taguchi, Koichi Ohshima, Kazuo Tamura, Shigeyoshi Makino, Hiroyuki Tsuda, Tomohiko Kamimura, Ryosuke Ogawa, Yasunobu Abe, Masakazu Higuchi, Kiyoshi Yamashita, Masahiro Iwahashi, Hisashi Gondo, Kunihiro Tsukazaki
Publikováno v:
Cancer Science. 100:1842-1847
We evaluated the usefulness of prognostic markers in patients with diffuse large B-cell lymphoma (DLBCL) treated with cyclophosphamide, vincristine, doxorubicin, and prednisolone (CHOP) +/- rituximab (R-CHOP) in Japan. We studied 730 patients with DL
Autor:
Naoki Harada, Atsushi Nonami, Hajime Hisaeda, Kenjiro Kamezaki, Liping Tu, Shoichiro Takeishi, Hisashi Gondo, Koji Nagafuji, Toshihiro Miyamoto, Yuya Kunisaki, Yoshikane Kikushige, Mine Harada, Takanori Teshima, Katsuto Takenaka, Tomohiko Kamimura, Yuju Ohno, Yayoi Matsuo, Tetsuya Eto
Publikováno v:
European Journal of Haematology. 79:317-321
Toxoplasmosis is a rare but rapidly fatal complication that can occur following hematopoietic stem cell transplantation (HSCT). Over a 17-yr period at our institutions, a definite diagnosis of toxoplasmosis was made in only two of 925 allogeneic HSCT
Autor:
Takahiro Fukuda, Keiko Sata, Yoshikane Kikushige, Hisashi Gondo, K. Aoki, Koji Nagafuji, Akihiko Numata, Toshihiro Miyamoto, Mine Harada, Ken Takase
Publikováno v:
Internal Medicine. 46:1011-1014
Isolated extramedullary (EM) relapses of acute myelogenous leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) have been reported to be rare, and are usually followed by bone marrow relapses. We report a 49-year-old ma
Autor:
Yasuo Morishima, Tsuyoshi Muta, Yoshihisa Kodera, Atae Utsunomiya, Mine Harada, Tetsuya Eto, Hisashi Gondo, Takakazu Kawase, Koji Kato, Tsunefumi Shibuya, Shuichi Taniguchi, Yoshinobu Kanda, Shunichi Kato
Publikováno v:
Biology of Blood and Marrow Transplantation. 13(1):90-99
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) from an HLA-matched related donor has been suggested to improve the poor prognosis of adult T-cell leukemia/lymphoma (ATLL). However, the infusion of HTLV-I–infected cells from HTLV-I
Autor:
Takashi Haro, Haruko Kakumitsu, Yoshihiro Yamashita, Koutarou Shide, Akihiko Numata, Hisashi Gondo, Hideaki Nakajima, Yasuo Oshima, Kazuya Shimoda, Ken Takase, Hiroyuki Mano, Toshihiro Miyamoto, Kouji Kato, Atsushi Iwama, Mine Harada, Kenjiro Kamezaki, Kenichi Aoki
Publikováno v:
Journal of Biological Chemistry. 280:12621-12629
The Janus kinase (Jak)-Stat pathway plays an essential role in cytokine signaling. Granulocyte colony-stimulating factor (G-CSF) promotes granulopoiesis and granulocytic differentiation, and Stat3 is the principle Stat protein activated by G-CSF. Upo